Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics
Fructose-1,6-diphosphate (FDP), a glycolytic metabolite, has been reported to protect susceptible organs during hypoxia or ischemia. However, there is paucity of human data on its pharmacokinetics after being exogenously administered. In the current study, the preliminary pharmacokinetics of FDP giv...
Saved in:
Main Authors: | Li Ting-Ting, Xie Jian-Zhong, Wang Ling, Gao Yang-Yang, Jiang Xue-Hua |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2015-06-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.1515/acph-2015-0020 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fructose 1,6-bisphosphatase 1 is a potential biomarker affecting the malignant phenotype and aerobic glycolysis in glioblastoma
by: Weihong Lu, et al.
Published: (2025-01-01) -
Pharmacokinetics of 7,8-dihydroxyflavone in neonatal mice with hypoxia-ischemia related brain injury
by: Sin Yin Lim, et al.
Published: (2025-01-01) -
HPV16 <em>E6</em> Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway
by: Georgios Konstantopoulos, et al.
Published: (2024-01-01) -
Kefir Prevents Adipose Tissue Growth Through the Induction of Apoptotic Elements in High-Fructose Corn Syrup-Fed Rats
by: Esra Aslan, et al.
Published: (2023-05-01) -
Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach
by: Tilal Elsaman, et al.
Published: (2025-01-01)